Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:51 PM UTC
| NCT Number | NCT05980949 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,000 participants |
| Active Locations | 147 sites in the US |
| Sponsor | Karuna Therapeutics |
| Last Updated on CT.gov | September 29, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT05980949 is currently recruiting participants. This phase3 study for alzheimer's disease is actively seeking new participants at 147 locations across the United States. The study is sponsored by Karuna Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05980949 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 147 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05980949 was last updated 2 weeks ago (September 29, 2026). HelloStudys verifies this status automatically.